Line 72: |
Line 72: |
| ==Drugs in This Group== | | ==Drugs in This Group== |
| | | |
− | | + | {| border="1" cellpadding="7" |
| + | |-style="background:#B0E0E6; color:black" |
| + | !'''Compound''' |
| + | !'''Relative glucocorticoid activity''' |
| + | !'''Relative mineralocorticoid activity''' |
| + | !'''Duration of effect (hours)''' |
| + | |- |
| + | |'''Hydrocortisone''' |
| + | |1 |
| + | |1 |
| + | |8-12 |
| + | |- style="background:#F0F8FF; color:black" |
| + | |'''Cortisone''' |
| + | |0.8 |
| + | |0.8 |
| + | |8-12 |
| + | |- style="background:#B0E0E6; color:black" |
| + | |'''Prednisolone''' |
| + | |4 |
| + | |0.8 |
| + | |12-36 |
| + | |- style="background:#F0F8FF; color:black" |
| + | |'''Prednisone''' |
| + | |4 |
| + | |0.8 |
| + | |12-36 |
| + | |- style="background:#B0E0E6; color:black" |
| + | |'''Methylprednisolone''' |
| + | |5 |
| + | |Minimal |
| + | 12-36 |
| + | |- style="background:#F0F8FF; color:black" |
| + | |'''Dexamethasone''' |
| + | |30 |
| + | |Minimal |
| + | |24-28 |
| + | |- style="background:#B0E0E6; color:black" |
| + | |'''Betamethasone''' |
| + | |30 |
| + | |Minimal |
| + | |24-48 |
| + | |- style="background:#F0F8FF; color:black" |
| + | |'''Fludrocortisone''' |
| + | |15 |
| + | |150 |
| + | |8-12 |
| + | |} |
| | | |
| ==Clinical Uses== | | ==Clinical Uses== |